Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:21 AM
Ignite Modification Date:
2025-12-25 @ 12:21 AM
NCT ID:
NCT06334458
Eligibility Criteria:
Inclusion Criteria:
* 1st degree healthy/asymptomatic relatives of patients with exocrine pancreatic cancer, where the patient satisfies one OR more of the following conditions:
* was diagnosed with pancreatobiliary cancer \<50 years of age;
* was diagnosed with pancreatobiliary cancer \>50 years of age AND personal history of any of the following cancers: Breast cancer, Ovarian, fallopian tube or primary peritoneal cancer, Melanoma, Colorectal cancer, Endometrial cancer, Prostate cancer, Oesophagogastric cancer, Urinary tract cancer, Small bowel cancer, Brain tumour, Sebaceous skin tumour;
* was confirmed diagnosis of any of the following conditions in the family: Hereditary Breast and Ovarian Cancer, Peutz-Jeghers syndrome, hereditary pancreatitis, Lynch Syndrome, Familial Atypical Multiple Mole Melanoma Syndrome;
* significant family history in first degree relatives for cancer (e.g. two or more cancers in one individual or the same cancer in more individuals;
* a single 1st degree relative with pancreatic cancer;
* being a patient alive after 5 years from diagnosis (cancer free or currently treated).
* Cancer free at the time of enrollment;
Exclusion Criteria:
* Individuals with comorbidities that adversely influence their ability to tolerate the screening procedures or the screen-detected findings, or tolerate treatment of an early- stage screen-detected cancer, or that limit their life expectancy.
* Subjects already diagnosed with cancer currently in treatment;
* Subjects who are already in the process of clinical assessment or included in a screening program for a suspected tumour.
* Contraindications for the Whole-Body Magnetic Resonance Imaging (WB-MRI) radiological exam
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06334458
Study Brief:
Protocol Section:
NCT06334458